Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Daniel Menold Insider Profile
4 Followers
Daniel Menold, VP Finance at CymaBay Therapeutics, holds 0.00 shares in CymaBay Therapeutics (Ticker: CBAY).
Daniel Menold CymaBay Therapeutics (CBAY)VP Finance
CymaBay Therapeutics (CBAY)
VP Finance
Not Ranked
Ranked #2,153 out of 98,743 Corporate Insiders
Daniel Menold has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Daniel Menold does not currently own shares as a corporate insider.
A breakdown of Daniel Menold's holdings
Insider Roles
Daniel Menold does not currently hold a role as a corporate insider.
Roles that Daniel Menold holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Daniel Menold
Daniel Menold's Trading History
List of latest transactions for each holding click on a transaction to see Daniel Menold's performance on stock
You May Also Like
Daniel Menold insider profile FAQ
What is the percentage of profitable transactions made by Daniel Menold?
The percentage of profitable transactions made by Daniel Menold is ―.
What is the average return per transaction made by Daniel Menold?
The average return per transaction made by Daniel Menold is ―.
What stocks does Daniel Menold hold?
Daniel Menold holds: CBAY stocks.
What was Daniel Menold’s latest transaction?
Daniel Menold latest transaction was an Uninformative Sell of $235.80K.
What was Daniel Menold's most profitable transaction?
Daniel Menold’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Daniel Menold's role in CymaBay Therapeutics?
Daniel Menold's role in CymaBay Therapeutics is VP Finance.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.